9/13/2013 9:02:00 AM
HACKENSACK, N.J., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Champions Oncology Inc. (OTC:CSBR) ("Champions"), a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced the signing of a new discovery and drug development partnership with Teva Pharmaceutical Industries LTD (NYSE:TEVA) which will utilize Champions TumorGraft™ technology platform to enhance and accelerate the clinical development of several of Teva's oncology compounds.
Help employers find you! Check out all the jobs and post your resume.
comments powered by